Suchergebnisse - "RET protein, human"

PubPharm (240)

1

Peritoneal effusion : an uncommon adverse effect of selective RET inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Belli, C. | Curigliano, G.

2

Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer

enthalten in: Anti-cancer drugs | 2024

von Cognigni, V. | Giudice, G. | Bozzetti, F. | +5

3

Non-syndromic Hirschsprung's disease as a result of a RET gene variant

enthalten in: Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica | 2024

von Gietz, R. | Armando, R. | Lobos, P. | +1

4

Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer : a case report

enthalten in: Diagnostic pathology | 2024

von Bedau, T. | Heydt, C. | Siebolts, U. | +5

5

The Pathogenic RET Val804Met Variant in Acromegaly : A New Clinical Phenotype?

enthalten in: International journal of molecular sciences | 2024

von Chiloiro, S. | Capoluongo, E. | Costanza, F. | +13

6

Multiple endocrine neoplasia and very early onset inflammatory bowel disease. An unexpected association

enthalten in: Medicina | 2024

von Rossi, S. | Baleani, S. | Prado, X. | +8

7

Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer : a case report

enthalten in: BMC pulmonary medicine | 2023

von Peng, Y. | Zheng, Z. | Zewen, W. | +3

8

Re : "A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion" by Wijewardene et al

enthalten in: Thyroid : official journal of the American Thyroid Association | 2023

von Szymczak, S. | Szpurka, A. | Lu, Z. | +1

9

Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma : A Case Series

enthalten in: Clinical lung cancer | 2023

von Fricke, J. | Wang, J. | Gallego, N. | +7

10

HER2-positive breast cancer progresses rapidly after pyrotinib resistance : acquired RET gene fusion and TP53 gene mutation are potential reasons

enthalten in: Anti-cancer drugs | 2023

von Jiang, F. | Lai, J. | Zhuo, X. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]